Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Organogenesis Holdings (ORGO) Net Income (2016 - 2025)

Organogenesis Holdings (ORGO) has 10 years of Net Income data on record, last reported at $53.2 million in Q4 2025.

  • For Q4 2025, Net Income rose 593.34% year-over-year to $53.2 million; the TTM value through Dec 2025 reached $46.5 million, up 5304.41%, while the annual FY2025 figure was $46.5 million, 5304.41% up from the prior year.
  • Net Income reached $53.2 million in Q4 2025 per ORGO's latest filing, up from $21.6 million in the prior quarter.
  • Across five years, Net Income topped out at $53.2 million in Q4 2025 and bottomed at -$18.8 million in Q1 2025.
  • Average Net Income over 5 years is $6.6 million, with a median of $6.4 million recorded in 2022.
  • Peak YoY movement for Net Income: surged 1373.02% in 2023, then plummeted 797.29% in 2025.
  • A 5-year view of Net Income shows it stood at $19.0 million in 2021, then crashed by 60.64% to $7.5 million in 2022, then crashed by 80.71% to $1.4 million in 2023, then skyrocketed by 431.37% to $7.7 million in 2024, then surged by 593.34% to $53.2 million in 2025.
  • Per Business Quant database, its latest 3 readings for Net Income were $53.2 million in Q4 2025, $21.6 million in Q3 2025, and -$9.4 million in Q2 2025.